These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 5001656)

  • 21. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution of variants resistant to ethambutol or to capreomycine in wild strains of Mycobacterium tuberculosis].
    Arima J; Igarashi H
    C R Seances Soc Biol Fil; 1972 Nov; 166(2):474-6. PubMed ID: 4122644
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sensitivity of M. tuberculosis and atypical mycobacteria to ethambutol, capreomycin and rifampicin].
    Schröder KH; Hensel J; Scheuch V
    Prax Pneumol; 1969 Oct; 23(10):683-94. PubMed ID: 4984409
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T; Minami Y; Maekawa Y; Oi Y
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation criteria of antitubercular drugs from microbiological view].
    Stur D; Thiel W
    Adv Clin Pharmacol; 1977; 14():59-65. PubMed ID: 413337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibilities of advances in the determination of drug resistance of tubercle bacilli].
    Buraczewska M
    Gruzlica; 1971 Aug; 39(8):729-37. PubMed ID: 4999630
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the sensitivity to TUM-N of tubercle bacilli isolated from tuberculous patients who had never employed TUM-N--for determination of the critical concentration of TUM-N resistance (author's transl)].
    Toyoara M
    Kekkaku; 1973 Sep; 48(9):405-10. PubMed ID: 4203986
    [No Abstract]   [Full Text] [Related]  

  • 30. The determination of resistance of M. tuberculosis to capreomycin.
    Schröder KH; Hensel I
    Antibiot Chemother; 1970; 16():69-72. PubMed ID: 4108899
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations.
    Perdigão J; Macedo R; Ribeiro A; Brum L; Portugal I
    Int J Antimicrob Agents; 2009 Apr; 33(4):334-8. PubMed ID: 19097862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
    Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
    J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.
    Lee AS; Othman SN; Ho YM; Wong SY
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4447-9. PubMed ID: 15504879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
    J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
    Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
    Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cooperative study of resistance to antibacilli drugs in M. Tuberculosis strains isolated from Tuberculosis patients. (Preliminary study)].
    Valdivia Alvarez JA; Jimenez Misas CA; Rodriguez R; Mederos Cuervo L; Echemendia Font M; Valdes L; Suarez R; Gonzalez R; Romero V; Heredia C; Tudela H; Hernandez M; Ruiz Landa A; Alvarez J
    Rev Cubana Med Trop; 1982; 34(2):119-25. PubMed ID: 6820701
    [No Abstract]   [Full Text] [Related]  

  • 40. [The change in drug resistance of resistant Mycobacterium tuberculosis H37Rv strains after successive transfers on Ogawa medium for seven years].
    Yamadori H; Shibata A; Inagake H
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):20-5. PubMed ID: 6442171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.